The most common FLT3 mutation is the FLT3 internal tandem duplication (ITD), which occurs in 15–30% of AML patients and is thought to refer to a ligand-independent, constitutive activation, resulting in increased cell survival and proliferation of AML cells4. This evidence concerns the gene FLT3 and acute myeloid leukemia.